Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

Hillevi Englund,Malin Degerman Gunnarsson,Rose Marie Brundin,Marie Hedlund,Lena Kilander,Lars Lannfelt,Frida Ekholm Pettersson

Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

2009

Hillevi Englund
Malin Degerman Gunnarsson
Rose Marie Brundin
Marie Hedlund
Lena Kilander
Lars Lannfelt
Frida Ekholm Pettersson

Background/Objective: The lowering of natively analyzed Aβ42 in cerebrospinal fluid (CSF) is used as a diagnostic tool in Alzheimer’s disease (AD). The presence of Aβ oligomers can

Keywords:

Pathology
Disease
Frontotemporal dementia
Medicine
Cerebrospinal fluid
aβ oligomers
amyloid β
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations